[Efficacy of vascular wall protection from atherosclerotic damage using various calcium antagonists].
The authors studied the effect of various calcium antagonists--verapamil (VP) and Mg2+ (MgCl2) on the character of affection of the vascular wall ulcer conditions of prolonged hypercholesterolemia (HCE). The blood cholesterol (CS) content increased by the end of the 8th month of HCE to eight-fold the value in intact animals. The specific atherosclerotic changes in this case occupied approximately 80% of the area of the thoracic aorta whose functional properties changed essentially. The values of constricting responses of bands to noradrenaline (NA) was 45% of that in intact rabbits, the dilatating responses to acetyl choline (AC) and nitroglycerin (NG) were 20% and 35% of those in intact animals, respectively. Combination of HCE with daily VP injection (1 mg) led to a decrease in the area of affection of the aorta by 20%, which hardly affected the severity of HCE. A slightly more pronounced than in animals only with HCE (controls) was the response of bands to NA, AC, and NG (by 5, 30, and 15%, respectively). The protective effect of MgCl2 (200 mg/kg) was more significant--the affected area of the thoracic aorta reduced by 50% as compared to the controls, the constricting response to NA was maintained at a level exceeding the control level by 25%, the dilatating responses to NG and AC exceeded the control values 2 and 1.5 times, respectively, on the average. The severity of HCE diminished by 50%. The results of the study indicate that the organic and, in particular, the inorganic blocking agents of the calcium canals possess a marked angioprotective action and may be applied for the prevention of vascular atherosclerosis.
Taranenko
V M
VM
Tishkin
S M
SM
Talaeva
T V
TV
Isaechkina
I M
IM
Bratus'
V V
VV
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects*; D015636:Magnesium Chloride / Q000627:therapeutic use*; D011817:Rabbits; D014700:Verapamil / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D015636:Magnesium Chloride; D014700:Verapamil
Effektivnost' zashchity sosudistoĭ stenki ot ateroskleroticheskogo povrezhdeniia razlichnymi kal'tsievymi antagonistami.